Positive Results Using Cannabinoids in Respiratory, Metabolic, Immunological, and Neurodegenerative Disorders, A Narrative Review
No Thumbnail Available
Date
2024
Journal Title
Journal ISSN
Volume Title
Publisher
Stephy Publishers
Abstract
Description
Cannabinoids' therapeutic potential has garnered significant attention worldwide, with studies displaying their remarkable effectiveness in treating a variety of ailments. These compounds are known for their anti-inflammatory and neuroprotective properties, leading to investigations into their antipsychotic, anxiolytic, and anticonvulsant properties. This narrative review aims to provide an up-to-date overview of the primary therapeutic applications of cannabinoids and their outcomes. We conducted an extensive search across three databases: PubMed, Google Scholar, and Scopus, selecting relevant materials following the PRISMA 2020 guidelines for systematic reviews, while recognizing that this review adopts a narrative approach. Cannabis, a plant with psychotropic attributes, has been subject to strict legal restrictions since the early 20th century, rooted in religious, socio-cultural, and political principles. Nevertheless, cannabinoids derived from the plant offer substantial therapeutic potential, particularly as adjuncts in pain management. Moreover, their efficacy has been demonstrated in various conditions, including respiratory, metabolic, immunological, and neurodegenerative disorders like Parkinson's and Alzheimer's. Recognizing the significance of the Cannabis plant in scientific research is crucial, as it paves the way for safer therapeutic alternatives with minimal side effects. Therefore, facilitating and prioritizing its study across various medical disciplines is essential.